No Data
US Stock MarketDetailed Quotes
PSTX Poseida Therapeutics
Watchlist
3.095
+0.105+3.51% Trading 12/06 12:14 ET
3.100High3.000Low148.71KVolume
3.020Open2.990Pre Close454.14KTurnover0.28%Turnover RatioLossP/E (TTM)295.96MMarket Cap8.82052wk HighLossP/E (Static)95.62MShares1.54052wk Low2.39P/B166.62MFloat Cap17.620Historical High--Dividend TTM53.84MShs Float1.540Historical Low--Div YieldTTM3.34%Amplitude3.053Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Poseida Therapeutics Company
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
Revenue Breakdown
Business
Currency:USD
2022/12/31
Stock NameRevenueRatio
Single Segment130.49M100.00%
News
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--